Artificial Intelligence
Machine learning, statistical modeling, and intelligent software for biomedical data interpretation.
AI • Biotechnology • Precision Medicine
Building the Future of AI-Powered Precision Medicine
GenMabs LLC is an AI-driven biotechnology company developing biomedical software platforms today while advancing future biological products for healthcare and precision medicine.
AI + Biomedical Innovation
Connecting clinical data, computational intelligence, and biotechnology R&D.
Who We Are
An AI-driven biotechnology company
GenMabs LLC focuses on developing technologies that bridge computational intelligence and life sciences. Our mission is to create next-generation tools for researchers, clinicians, biotechnology companies, and healthcare innovators.
We believe the future of medicine will be shaped by the integration of artificial intelligence, biomedical research, clinical data science, and biotechnology.
Featured Product
Now Available
OncoAI™
AI-Powered Cancer Survival Prediction Platform
OncoAI is our first-generation clinical AI platform designed to assist researchers and healthcare professionals in analyzing cancer survival risk using statistical modeling, machine learning, and cohort-level analytics.
Individual prediction
Batch prediction
Survival analysis
Risk stratification
Export-ready cohort reports
Technology
Where AI meets biotechnology
Clinical Data Science
Risk modeling, survival analysis, cohort analytics, and decision-support workflows.
Biotechnology R&D
Future programs in therapeutic antibodies, biomarker discovery, and AI-assisted drug discovery.
Pipeline
Software today. Biological innovation tomorrow.
Current
OncoAI™
Clinical AI platform for cancer survival prediction and cohort analytics.
In Development
TumorGPT™
AI assistant concept for oncology research, biomedical interpretation, and precision medicine workflows.
Future Programs
Biotechnology Products
Potential future programs in therapeutic antibodies, biomarkers, diagnostics, and AI-assisted drug discovery.
Responsible Innovation
GenMabs develops research and decision-support technologies. OncoAI outputs are intended for research, evaluation, and decision-support contexts and should not be used as the sole basis for direct clinical decisions.
Contact
GenMabs LLC
AI-driven biotechnology company based in Georgia, United States.
Email: info@genmabsbio.com
Website: genmabsbio.com
Products: OncoAI™, TumorGPT™